Company · CIK 1808158
Repare Therapeutics Inc.
| CIK | 1808158 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | Z4 |
| Business address | Quebec, Canada |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-13 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-281298 | 2024-08-06 | 2026-01-30 | 4 | |
| 333-257668 | 2021-07-02 | 2022-08-04 | 5 | |
| 333-238822 | 2020-05-29 | 2020-06-19 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-30 | EFFECTDeclared effective | 333-281298 | 9999999995-26-000362 |
| 2024-11-07 | 424B5Shelf takedown | 333-281298 | 0001193125-24-252708 |
| 2024-08-19 | EFFECTDeclared effective | 333-281298 | 9999999995-24-002576 |
| 2024-08-06 | S-3Shelf registered | 333-281298 | 0001193125-24-194944 |
| 2022-08-04 | 424B5Shelf takedown | 333-257668 | 0001193125-22-212631 |
| 2022-04-25 | EFFECTDeclared effective | 333-257668 | 9999999995-22-001070 |
| 2021-10-28 | 424B5Shelf takedown | 333-257668 | 0001193125-21-311544 |
| 2021-10-27 | 424B5Shelf takedown | 333-257668 | 0001193125-21-309434 |
| 2021-07-02 | S-3ASRShelf registered | 333-257668 | 0001193125-21-207709 |
| 2020-06-19 | 424B4Final prospectus | 333-238822 | 0001193125-20-174103 |
| 2020-06-18 | EFFECTDeclared effective | 333-238822 | 9999999995-20-001477 |
| 2020-06-17 | S-1/AAmendment | 333-238822 | 0001193125-20-171293 |
| 2020-06-15 | S-1/AAmendment | 333-238822 | 0001193125-20-168295 |
| 2020-05-29 | S-1Registration filed | 333-238822 | 0001193125-20-155961 |
| 2020-04-06 | DRSDraft made public | 377-03112 | 0000950123-20-003130 |